NIST gives $135M to NIIMBL to bolster U.S. supply chains

By The Science Advisory Board staff writers

July 15, 2021 -- The U.S. National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) announced it has received $153 million in new funding from the National Institute of Standards and Technology (NIST).

The funding comes in the form of two awards -- one for $70 million to continue operations for an additional five years and one for $83 million for COVID-19 pandemic response projects under the American Rescue Plan (ARP).

U.S. Commerce Secretary Gina Raimondo announced the awards at NIIMBL's recent national meeting in Washington, DC.

NIIMBL was launched in 2017. To date, the institute has more than 180 members in large industry, small-medium size companies, academic institutions, nonprofits, and federal agency partners. NIIMBL has led more than 70 large-scale biopharmaceutical manufacturing innovation projects over the past five years.


Copyright © 2021 scienceboard.net
 


Email Address:

First Name:

Last Name:

I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.